Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

64.61
Delayed Data
As of Aug 26
 -0.11 / -0.17%
Today’s Change
45.45
Today|||52-Week Range
68.12
+9.06%
Year-to-Date
Dividend Aristocrat Correlation Pairs
9:00pm / GuruFocus News - Paid Partner Content
Johnson & Johnson Could Become the First Company to Reach a $1 Trillion Valuation
Aug 22 / MotleyFool.com - Paid Partner Content
Pharma Has History of Price Gouging, Mylan Should Be No Surprise
Aug 26 / TheStreet.com - Paid Partner Content
Here's the Best Dividend Stock in Big Pharma
Aug 21 / MotleyFool.com - Paid Partner Content
Why EpiPen, Why Now: Analysts Explain the Timing of Mylan's Trouble
Aug 24 / TheStreet.com - Paid Partner Content
Zacks Value Investor Highlights: AbbVie, Berry Plastics, Hawaiian Holdings, Toll Brot...
Aug 19 / Zacks.com - Paid Partner Content
Why OraSure Technologies, Inc is Jumping Today
Aug 24 / MotleyFool.com - Paid Partner Content
3 Cheap Dividend Stocks You Can Buy Right Now
Aug 19 / MotleyFool.com - Paid Partner Content
Pfizer makes $14bn bet on cancer drugmaker Medivation
Aug 22 / FT.com - Paid Partner Content
10 Highest Healthcare Dividend Stocks
Aug 18 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close64.72
Today’s open64.68
Day’s range64.21 - 65.02
Volume7,041,630
Average volume (3 months)8,398,394
Market cap$105.2B
Dividend yield3.53%
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+11.89%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+14.52%
P/E ratio18.6
Price/Sales4.24
Price/Book26.37

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.19-0.43%
SNYSanofi+0.34+0.88%
BMYBristol-Myers Squibb+0.01+0.02%
AGNAllergan+1.62+0.69%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateOctober 28, 2016
EPS forecast (this quarter)$1.20
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers

Search for Jobs